These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36894904)

  • 1. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
    Vrana JA; Theis JD; Dasari S; Mereuta OM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kurtin PJ; Grogg KL; Dogan A
    Haematologica; 2014 Jul; 99(7):1239-47. PubMed ID: 24747948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
    Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
    Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
    Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
    Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry.
    Gonzalez Suarez ML; Zhang P; Nasr SH; Sathick IJ; Kittanamongkolchai W; Kurtin PJ; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera Hernandez LP; Said SM; Sethi S; Dispenzieri A; Gertz MA; Leung N
    Kidney Int; 2019 Oct; 96(4):1005-1009. PubMed ID: 31447055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
    Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
    Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pilot Study of Rare Renal Amyloidosis Based on FFPE Proteomics.
    Meng S; Xia W; Xia L; Zhou L; Xu J; Pan X; Meng L
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
    Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
    Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
    Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
    J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies.
    Mangione PP; Mazza G; Gilbertson JA; Rendell NB; Canetti D; Giorgetti S; Frenguelli L; Curti M; Rezk T; Raimondi S; Pepys MB; Hawkins PN; Gillmore JD; Taylor GW; Pinzani M; Bellotti V
    J Proteomics; 2017 Aug; 165():113-118. PubMed ID: 28647518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.